Literature DB >> 1428797

Chronic spastic atrophic hemiparesis with benign course.

M Casmiro1, M Sintini, P Martinelli, M Leonardi, R D'Alessandro.   

Abstract

We present the clinical and neuroimaging data of 4 patients (mean age: 62 years, range 54-67; mean follow-up: 19.5 years, range: 26 months-29 years) with chronic spastic atrophic hemiparesis (CSAH). Neuroimaging findings were non specific, CT scan and MRI showing white matter lesions located within the centrum semiovale in two cases, parieto-occipital lobe and pons in one case each. This study underlines that patients with CSAH may have a good long-term prognosis. MRI studies may demonstrate associated lesions within the white matter or brainstem and are advisable in all subjects with CSAH, but further studies are necessary to clarify the nature of the observed lesions.

Entities:  

Mesh:

Year:  1992        PMID: 1428797     DOI: 10.1007/bf02233407

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  6 in total

1.  [Ascendant and progressive hemiplegia of the Mills type with abnormality of the cervico-occipital joint].

Authors:  R LABAUGE; A MENARD; L SIMON
Journal:  Rev Neurol (Paris)       Date:  1960-11       Impact factor: 2.607

2.  Diagnostic localizing value of muscle atrophy in parietal lobe lesions.

Authors:  A SILVERSTEIN
Journal:  Neurology       Date:  1955-01       Impact factor: 9.910

3.  [Revision of Mills' syndrome].

Authors:  P COSSA
Journal:  Presse Med       Date:  1952-03-26       Impact factor: 1.228

4.  [New proof of the cerebral origin of Mills syndrome].

Authors:  P COSSA
Journal:  Rev Neurol (Paris)       Date:  1951       Impact factor: 2.607

5.  Role of MRI in the diagnosis of Mills syndrome.

Authors:  G Dalla Volta; M Magoni; D Vangi; L A Vignolo
Journal:  Ital J Neurol Sci       Date:  1989-10

6.  [Clinical variants of amyotrophic lateral sclerosis: hemiplegic type of ALS and Mills syndrome. A critical review].

Authors:  J P Malin; R Poburski; E Reusche
Journal:  Fortschr Neurol Psychiatr       Date:  1986-04       Impact factor: 0.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.